The differential distribution of PD-1 and PD-L1 in and (containing cancer) tissues provides a new approach to immunotherapy of harmful tumors, and anti-PD-L1/PD-1 disease-fighters have been used in the treatment of tumors to bring significant results [5]. This evidence concerns the gene CD274 and cancer.